VFA
Values First Advisors’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
376,003
+756
| +0.2% | +$4.82K | 1.31% | 13 |
|
|
2025
Q1 | $1.81M | Sell |
375,247
-1,445
| -0.4% | -$6.99K | 1.06% | 24 |
|
|
2024
Q4 | $3.6M | Sell |
376,692
-79,516
| -17% | -$760K | 1.98% | 8 |
|
|
2024
Q3 | $3.81M | Sell |
456,208
-9,943
| -2% | -$83K | 2.07% | 6 |
|
|
2024
Q2 | $3.18M | Sell |
466,151
-3,936
| -0.8% | -$26.8K | 1.9% | 6 |
|
|
2024
Q1 | $1.19M | Buy |
470,087
+162,195
| +53% | +$410K | 0.7% | 44 |
|
|
2023
Q4 | $739K | Buy |
307,892
+155,193
| +102% | +$372K | 0.45% | 74 |
|
|
2023
Q3 | $519K | Buy |
152,699
+101,796
| +200% | +$346K | 0.34% | 91 |
|
|
2023
Q2 | $374K | Buy |
50,903
+1,282
| +3% | +$9.42K | 0.23% | 113 |
|
|
2023
Q1 | $514K | Buy |
49,621
+15,679
| +46% | +$162K | 0.33% | 86 |
|
|
2022
Q4 | $401K | Buy |
33,942
+19,929
| +142% | +$235K | 0.28% | 97 |
|
|
2022
Q3 | $294K | Buy |
+14,013
| New | +$294K | 0.21% | 110 |
|
|
2022
Q2 | – | Sell |
-6,477
| Closed | -$266K | – | 161 |
|
|
2022
Q1 | $266K | Buy |
6,477
+976
| +18% | +$40.1K | 0.17% | 133 |
|
|
2021
Q4 | $239K | Buy |
+5,501
| New | +$239K | 0.14% | 144 |
|
|
2021
Q3 | – | Sell |
-3,593
| Closed | -$226K | – | 150 |
|
|
2021
Q2 | $226K | Buy |
+3,593
| New | +$226K | 0.15% | 135 |
|